{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:14:57Z","timestamp":1789586097652,"version":"build-2803163510"},"posted":{"date-parts":[[2025,6,2]]},"group-title":"Bioinformatics","reference-count":136,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T00:00:00Z","timestamp":1748822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"award":["R21AI169301"],"award-info":[{"award-number":["R21AI169301"]}],"id":[{"id":"https:\/\/ror.org\/043z4tv69","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Translational Research Scholars Program"],"award-info":[{"award-number":["Translational Research Scholars Program"]}],"id":[{"id":"https:\/\/ror.org\/03wmf1y16","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Start-up funds"],"award-info":[{"award-number":["Start-up funds"]}],"id":[{"id":"https:\/\/ror.org\/03wmf1y16","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Tuberculosis (TB) remains the leading cause of infectious disease mortality worldwide, killing over one million people annually. Rising antibiotic resistance has added urgency to the need for host-directed therapeutics (HDTs) that modulate host immune responses alongside directly targeting the pathogen. Repurposing FDA-approved drugs is particularly attractive for this purpose because their safety profiles are already well established, substantially reducing development time and cost. Transcriptomic methods have successfully identified repurposable therapeutics for TB based on \u2018connectivity mapping,\u2019 which identifies drugs that reverse disease gene expression patterns. However, these applications are limited to a small subset of data belonging to a specific data platform and a few connectivity methods. Expanding beyond these constrained settings introduces substantial challenges, including dataset heterogeneity across transcriptomics platforms and biological conditions, uncertainty about optimal scoring methods, and the lack of systematic approaches to identify robust disease signatures. We developed a computational workflow that integrates 28 TB gene expression signatures and multiple connectivity scoring methods to capture dominant TB signals regardless of variation in microarray and RNAseq platforms, cell types, and infection conditions. We systematically identified 64 FDA-approved drugs as promising TB host-directed therapeutics. These high-confidence drug candidates include known HDTs such as statins (rosuvastatin, fluvastatin, lovastatin) and tamoxifen, recently validated in experimental TB models. Our prioritized candidate drugs reveal enrichment for therapeutically TB-relevant mechanisms, e.g., cholesterol metabolism inhibition and immune modulation pathways. Network analysis of disease-drug interactions identified 12 key bridging genes (including\n                  <jats:italic>IL-8<\/jats:italic>\n                  ,\n                  <jats:italic>CXCR2<\/jats:italic>\n                  ) that represent potential novel druggable targets for TB host-directed therapy. This work establishes transcriptome-based connectivity mapping as a viable approach for systematic HDT discovery in bacterial infections and provides a robust computational framework applicable to other infectious diseases. Our findings offer immediate opportunities for experimental validation of prioritized drug candidates and mechanistic investigation of identified druggable targets in TB pathogenesis.\n                <\/jats:p>","DOI":"10.1101\/2025.06.02.657296","type":"posted-content","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T12:15:20Z","timestamp":1748866520000},"source":"Crossref","is-referenced-by-count":3,"title":["Integrative transcriptome-based drug repurposing in tuberculosis"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3134-8846","authenticated-orcid":false,"given":"Kewalin","family":"Samart","sequence":"first","affiliation":[{"name":"Computational Bioscience Program, School of Medicine, University of Colorado Anschutz, Aurora, CO, USA"},{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3983-093X","authenticated-orcid":false,"given":"Ling","family":"Thang","sequence":"additional","affiliation":[{"name":"Computer Science undergraduate program, Metropolitan State University, Denver, CO, USA"},{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9994-5419","authenticated-orcid":false,"given":"Landon","family":"Buskirk","sequence":"additional","affiliation":[{"name":"Data Science undergraduate program, Michigan State University, East Lansing, MI, USA"},{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5034-2059","authenticated-orcid":false,"given":"Amy","family":"Tonielli","sequence":"additional","affiliation":[{"name":"Biomedical Laboratory Science undergraduate program, Michigan State University, East Lansing, MI, USA"},{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-4110","authenticated-orcid":false,"given":"Arjun","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7443-925X","authenticated-orcid":false,"given":"Janani","family":"Ravi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, Center for Health Artificial Intelligence, University of Colorado Anschutz, Aurora, CO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026041200364921000_2025.06.02.657296v2.1","unstructured":"World Health Organization. Global Tuberculosis Report 2023. (2023)."},{"key":"2026041200364921000_2025.06.02.657296v2.2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis","volume":"5","year":"2017","journal-title":"Lancet Respir. Med"},{"key":"2026041200364921000_2025.06.02.657296v2.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.162"},{"key":"2026041200364921000_2025.06.02.657296v2.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.05.005"},{"key":"2026041200364921000_2025.06.02.657296v2.5","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12951"},{"key":"2026041200364921000_2025.06.02.657296v2.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00070-0"},{"key":"2026041200364921000_2025.06.02.657296v2.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4696"},{"key":"2026041200364921000_2025.06.02.657296v2.8","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00032-13"},{"key":"2026041200364921000_2025.06.02.657296v2.9","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180530100332"},{"key":"2026041200364921000_2025.06.02.657296v2.10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-biodatasci-110123-025333","article-title":"Computational Approaches to Drug Repurposing: Methods","volume":"7","year":"2024","journal-title":"Challenges, and Opportunities. Annu. Rev. Biomed. Data Sci"},{"key":"2026041200364921000_2025.06.02.657296v2.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2044"},{"key":"2026041200364921000_2025.06.02.657296v2.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"2026041200364921000_2025.06.02.657296v2.13","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab161"},{"key":"2026041200364921000_2025.06.02.657296v2.14","doi-asserted-by":"crossref","unstructured":"Atri, P. et al. Connectivity mapping-based identification of pharmacological inhibitor targeting HDAC6 in aggressive pancreatic ductal adenocarcinoma. Npj Precis . Oncol. 8, 66 (2024).","DOI":"10.1038\/s41698-024-00562-5"},{"key":"2026041200364921000_2025.06.02.657296v2.15","doi-asserted-by":"crossref","unstructured":"Raghavan, R. et al. Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer. BMC Genomics 17, 811 (2016).","DOI":"10.1186\/s12864-016-3149-5"},{"key":"2026041200364921000_2025.06.02.657296v2.16","doi-asserted-by":"crossref","unstructured":"Zhao, Y. , Chen, X. , Chen, J. & Qi, X . Decoding Connectivity Map-based drug repurposing for oncotherapy. Brief. Bioinform. 24, bbad142 (2023).","DOI":"10.1093\/bib\/bbad142"},{"key":"2026041200364921000_2025.06.02.657296v2.17","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03150-4"},{"key":"2026041200364921000_2025.06.02.657296v2.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56690-4"},{"key":"2026041200364921000_2025.06.02.657296v2.19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41398-019-0555-x","article-title":"Drug repurposing for Alzheimer\u2019s disease based on transcriptional profiling of human iPSC-derived cortical neurons","volume":"9","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"2026041200364921000_2025.06.02.657296v2.20","doi-asserted-by":"crossref","unstructured":"Wang, Z. , Arat, S. , Magid-Slav, M. & Brown, J. R . Meta-analysis of human gene expression in response to Mycobacterium tuberculosis infection reveals potential therapeutic targets. BMC Syst. Biol. 12, 3 (2018).","DOI":"10.1186\/s12918-017-0524-z"},{"key":"2026041200364921000_2025.06.02.657296v2.21","doi-asserted-by":"crossref","first-page":"e1010744","DOI":"10.1371\/journal.pcbi.1010744","article-title":"Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB\/HIV co-infections for drug repurposing","volume":"18","year":"2022","journal-title":"PLOS Comput. Biol"},{"key":"2026041200364921000_2025.06.02.657296v2.22","doi-asserted-by":"crossref","first-page":"1041892","DOI":"10.3389\/fgene.2023.1041892","article-title":"Integrated bioinformatic analyses investigate macrophage-M1-related biomarkers and tuberculosis therapeutic drugs","volume":"14","year":"2023","journal-title":"Front. Genet"},{"key":"2026041200364921000_2025.06.02.657296v2.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97005-z"},{"key":"2026041200364921000_2025.06.02.657296v2.24","doi-asserted-by":"crossref","unstructured":"Gonzalez Gomez, C. , Rosa-Calatrava, M. & Fouret, J. Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking. Brief. Bioinform. 25, bbae299 (2024).","DOI":"10.1093\/bib\/bbae299"},{"key":"2026041200364921000_2025.06.02.657296v2.25","first-page":"540","article-title":"Systematic evaluation of connectivity map for disease indications","volume":"6","year":"2014","journal-title":"Genome Med"},{"key":"2026041200364921000_2025.06.02.657296v2.26","doi-asserted-by":"publisher","DOI":"10.1109\/BIBM.2013.6732481"},{"key":"2026041200364921000_2025.06.02.657296v2.27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae552"},{"key":"2026041200364921000_2025.06.02.657296v2.28","first-page":"e03456","article-title":"Improving gene set enrichment analysis (GSEA) by using regulation directionality","volume":"12","year":"2024","journal-title":"Microbiol. Spectr"},{"key":"2026041200364921000_2025.06.02.657296v2.29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022486118"},{"key":"2026041200364921000_2025.06.02.657296v2.30","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw014"},{"key":"2026041200364921000_2025.06.02.657296v2.31","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01836-16"},{"key":"2026041200364921000_2025.06.02.657296v2.32","doi-asserted-by":"crossref","unstructured":"Guerra-De-Blas, P. D. C. et al. Potential Effect of Statins on Mycobacterium tuberculosis Infection. J. Immunol. Res. 2018, 7617023 (2018).","DOI":"10.1155\/2018\/7617023"},{"key":"2026041200364921000_2025.06.02.657296v2.33","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02097"},{"key":"2026041200364921000_2025.06.02.657296v2.34","first-page":"e03024","article-title":"Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis","volume":"14","year":"2023","journal-title":"mBio"},{"key":"2026041200364921000_2025.06.02.657296v2.35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3578-9_5"},{"key":"2026041200364921000_2025.06.02.657296v2.36","unstructured":"Greene, C. S. , et al. refine.bio: a resource of uniformly processed publicly available gene expression datasets. (2023)."},{"key":"2026041200364921000_2025.06.02.657296v2.37","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3838"},{"key":"2026041200364921000_2025.06.02.657296v2.38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007"},{"key":"2026041200364921000_2025.06.02.657296v2.39","doi-asserted-by":"crossref","unstructured":"Love, M. I. , Huber, W. & Anders, S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026041200364921000_2025.06.02.657296v2.40","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa878"},{"key":"2026041200364921000_2025.06.02.657296v2.41","doi-asserted-by":"crossref","unstructured":"Chen, B. et al. Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat. Commun. 8, 16022 (2017).","DOI":"10.1038\/ncomms16022"},{"key":"2026041200364921000_2025.06.02.657296v2.42","doi-asserted-by":"crossref","first-page":"5378","DOI":"10.1038\/s41467-024-49620-3","article-title":"Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery","volume":"15","year":"2024","journal-title":"Nat. Commun"},{"key":"2026041200364921000_2025.06.02.657296v2.43","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4306"},{"key":"2026041200364921000_2025.06.02.657296v2.44","first-page":"3151","article-title":"EMUDRA: Ensemble of Multiple Drug Repositioning Approaches to improve prediction accuracy","volume":"34","year":"2018","journal-title":"Bioinforma. Oxf. Engl"},{"key":"2026041200364921000_2025.06.02.657296v2.45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-258"},{"key":"2026041200364921000_2025.06.02.657296v2.46","doi-asserted-by":"crossref","unstructured":"A, S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, (2005).","DOI":"10.1073\/pnas.0506580102"},{"key":"2026041200364921000_2025.06.02.657296v2.47","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-32833-1_379"},{"key":"2026041200364921000_2025.06.02.657296v2.48","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac621"},{"key":"2026041200364921000_2025.06.02.657296v2.49","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7920"},{"key":"2026041200364921000_2025.06.02.657296v2.50","doi-asserted-by":"publisher","DOI":"10.1038\/75556"},{"key":"2026041200364921000_2025.06.02.657296v2.51","first-page":"100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","year":"2021","journal-title":"The Innovation"},{"key":"2026041200364921000_2025.06.02.657296v2.52","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-166"},{"key":"2026041200364921000_2025.06.02.657296v2.53","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.13"},{"key":"2026041200364921000_2025.06.02.657296v2.54","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1040"},{"key":"2026041200364921000_2025.06.02.657296v2.55","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKAC1000"},{"key":"2026041200364921000_2025.06.02.657296v2.56","doi-asserted-by":"publisher","DOI":"10.1007\/BF01386390"},{"key":"2026041200364921000_2025.06.02.657296v2.57","unstructured":"Padda, I. S. & Muralidhara Reddy, K. Antitubercular Medications. in StatPearls (StatPearls Publishing, Treasure Island (FL), 2025)."},{"key":"2026041200364921000_2025.06.02.657296v2.58","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1007"},{"key":"2026041200364921000_2025.06.02.657296v2.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2015.09.001"},{"key":"2026041200364921000_2025.06.02.657296v2.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1744-7348.1939.tb06990.x"},{"key":"2026041200364921000_2025.06.02.657296v2.61","doi-asserted-by":"publisher","DOI":"10.1007\/BF02322290"},{"key":"2026041200364921000_2025.06.02.657296v2.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-6997(25)00026-2"},{"key":"2026041200364921000_2025.06.02.657296v2.63","first-page":"1","article-title":"A similarity measure for indefinite rankings","volume":"28","year":"2010","journal-title":"ACM Trans. Inf. Syst"},{"key":"2026041200364921000_2025.06.02.657296v2.64","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100926"},{"key":"2026041200364921000_2025.06.02.657296v2.65","doi-asserted-by":"publisher","DOI":"10.1038\/nature09247"},{"key":"2026041200364921000_2025.06.02.657296v2.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.07.003"},{"key":"2026041200364921000_2025.06.02.657296v2.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110983"},{"key":"2026041200364921000_2025.06.02.657296v2.68","doi-asserted-by":"publisher","DOI":"10.1038\/srep42225"},{"key":"2026041200364921000_2025.06.02.657296v2.69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26045-w"},{"key":"2026041200364921000_2025.06.02.657296v2.70","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1038\/s41598-022-20409-y","article-title":"Comparative transcriptomic analysis of whole blood mycobacterial growth assays and tuberculosis patients\u2019 blood RNA profiles","volume":"12","year":"2022","journal-title":"Sci. Rep"},{"key":"2026041200364921000_2025.06.02.657296v2.71","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12864-025-11548-3","article-title":"An updated comparison of microarray and RNA-seq for concentration response transcriptomic study: case studies with two cannabinoids, cannabichromene and cannabinol","volume":"26","year":"2025","journal-title":"BMC Genomics"},{"key":"2026041200364921000_2025.06.02.657296v2.72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jor.23661","article-title":"Advantages of RNA-seq compared to RNA microarrays for transcriptome profiling of anterior cruciate ligament tears","volume":"36","year":"2018","journal-title":"J. Orthop. Res"},{"key":"2026041200364921000_2025.06.02.657296v2.73","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2019.4293"},{"key":"2026041200364921000_2025.06.02.657296v2.74","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00974-07"},{"key":"2026041200364921000_2025.06.02.657296v2.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107795"},{"key":"2026041200364921000_2025.06.02.657296v2.76","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/infdis\/jiz517","article-title":"Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice","volume":"221","year":"2020","journal-title":"J. Infect. Dis"},{"key":"2026041200364921000_2025.06.02.657296v2.77","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.22.0548"},{"key":"2026041200364921000_2025.06.02.657296v2.78","first-page":"e03197","article-title":"Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas","volume":"11","year":"2023","journal-title":"Microbiol. Spectr"},{"key":"2026041200364921000_2025.06.02.657296v2.79","doi-asserted-by":"publisher","DOI":"10.3390\/cells13060536"},{"key":"2026041200364921000_2025.06.02.657296v2.80","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1021\/acsabm.4c01723","article-title":"Host-Directed Therapy with Inhalable Lovastatin Microspheres for Matrix Metalloproteinase Inhibition in Tuberculosis","volume":"8","year":"2025","journal-title":"ACS Appl. Bio Mater"},{"key":"2026041200364921000_2025.06.02.657296v2.81","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00067-1"},{"key":"2026041200364921000_2025.06.02.657296v2.82","doi-asserted-by":"crossref","first-page":"10475","DOI":"10.1038\/s41467-024-54419-3","article-title":"PET-CT outcomes from a randomised controlled trial of rosuvastatin as an adjunct to standard tuberculosis treatment","volume":"15","year":"2024","journal-title":"Nat. Commun"},{"key":"2026041200364921000_2025.06.02.657296v2.83","first-page":"550","article-title":"Novel Treatments against Mycobacterium tuberculosis Based on Drug Repurposing","volume":"9","year":"2020","journal-title":"Antibiot. Basel Switz"},{"key":"2026041200364921000_2025.06.02.657296v2.84","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ebiom.2015.07.014","article-title":"Efficacy of Adjunctive Tofacitinib Therapy in Mouse Models of Tuberculosis","volume":"2","year":"2015","journal-title":"EBioMedicine"},{"key":"2026041200364921000_2025.06.02.657296v2.85","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ621"},{"key":"2026041200364921000_2025.06.02.657296v2.86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2309664121"},{"key":"2026041200364921000_2025.06.02.657296v2.87","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/eji.201847656","article-title":"The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function","volume":"48","year":"2018","journal-title":"Eur. J. Immunol"},{"key":"2026041200364921000_2025.06.02.657296v2.88","doi-asserted-by":"crossref","first-page":"e64834","DOI":"10.7554\/eLife.64834","article-title":"The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy","volume":"12","year":"2023","journal-title":"eLife"},{"key":"2026041200364921000_2025.06.02.657296v2.89","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0226-5"},{"key":"2026041200364921000_2025.06.02.657296v2.90","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02777-6"},{"key":"2026041200364921000_2025.06.02.657296v2.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.09.010"},{"key":"2026041200364921000_2025.06.02.657296v2.92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09955-8"},{"key":"2026041200364921000_2025.06.02.657296v2.93","first-page":"288","article-title":"Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice. Commun","volume":"2","year":"2019","journal-title":"Biol"},{"key":"2026041200364921000_2025.06.02.657296v2.94","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit152"},{"key":"2026041200364921000_2025.06.02.657296v2.95","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/infdis\/jiad390","article-title":"The Cyclooxygenase 2 Inhibitor Etoricoxib as Adjunctive Therapy in Tuberculosis Impairs Macrophage Control of Mycobacterial Growth","volume":"229","year":"2024","journal-title":"J. Infect. Dis"},{"key":"2026041200364921000_2025.06.02.657296v2.96","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3892\/mmr.2022.12712","article-title":"Estradiol inhibits autophagy of Mycobacterium tuberculosis -infected 16HBE cells and controls the proliferation of intracellular Mycobacterium tuberculosis","volume":"25","year":"2022","journal-title":"Mol. Med. Rep"},{"key":"2026041200364921000_2025.06.02.657296v2.97","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.it.2022.06.004","article-title":"Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosis","volume":"43","year":"2022","journal-title":"Trends Immunol"},{"key":"2026041200364921000_2025.06.02.657296v2.98","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-024-01943-z"},{"key":"2026041200364921000_2025.06.02.657296v2.99","doi-asserted-by":"crossref","unstructured":"Krupa, A. et al. Binding of CXCL8\/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response. Mediators Inflamm. 2015, 124762 (2015).","DOI":"10.1155\/2015\/124762"},{"key":"2026041200364921000_2025.06.02.657296v2.100","doi-asserted-by":"crossref","first-page":"13261","DOI":"10.3390\/ijms241713261","article-title":"Molecular Markers of Early Immune Response in Tuberculosis: Prospects of Application in Predictive Medicine","volume":"24","year":"2023","journal-title":"Int. J. Mol. Sci"},{"key":"2026041200364921000_2025.06.02.657296v2.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115072"},{"key":"2026041200364921000_2025.06.02.657296v2.102","doi-asserted-by":"crossref","unstructured":"Alfarsi, L. H. et al. PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer. BMC Cancer 20, 425 (2020).","DOI":"10.1186\/s12885-020-06939-6"},{"key":"2026041200364921000_2025.06.02.657296v2.103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.015","article-title":"Discovery of the Oncogenic Parp1, a Target of bcr-abl and a Potential Therapeutic, in mir-181a\/PPFIA1 Signaling Pathway","volume":"16","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"2026041200364921000_2025.06.02.657296v2.104","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.omtn.2023.04.026","article-title":"PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration","volume":"32","year":"2023","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"2026041200364921000_2025.06.02.657296v2.105","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06061-0"},{"key":"2026041200364921000_2025.06.02.657296v2.106","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.25122"},{"key":"2026041200364921000_2025.06.02.657296v2.107","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000453454","article-title":"Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs","volume":"9","year":"2017","journal-title":"J. Innate Immun"},{"key":"2026041200364921000_2025.06.02.657296v2.108","doi-asserted-by":"crossref","unstructured":"Arnett, E. et al. Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosis. Biomed. Pharmacother. 168, 115738 (2023).","DOI":"10.1016\/j.biopha.2023.115738"},{"key":"2026041200364921000_2025.06.02.657296v2.109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007100"},{"key":"2026041200364921000_2025.06.02.657296v2.110","doi-asserted-by":"crossref","first-page":"e0281170","DOI":"10.1371\/journal.pone.0281170","article-title":"Inhibition of mycobacteria proliferation in macrophages by low cisplatin concentration through phosphorylated p53-related apoptosis pathway","volume":"18","year":"2023","journal-title":"PLOS ONE"},{"key":"2026041200364921000_2025.06.02.657296v2.111","doi-asserted-by":"crossref","unstructured":"Zhang, Y. , et al. DHX36 , BAX , and ARPC1B May Be Critical for the Diagnosis and Treatment of Tuberculosis. Can. Respir. J. 2020, 1\u201311 (2020).","DOI":"10.1155\/2020\/4348371"},{"key":"2026041200364921000_2025.06.02.657296v2.112","doi-asserted-by":"crossref","unstructured":"Upadhyay, R. et al. Host Directed Therapy for Chronic Tuberculosis via Intrapulmonary Delivery of Aerosolized Peptide Inhibitors Targeting the IL-10-STAT3 Pathway. Sci. Rep. 8, 16610 (2018).","DOI":"10.1038\/s41598-018-35023-0"},{"key":"2026041200364921000_2025.06.02.657296v2.113","doi-asserted-by":"crossref","first-page":"19794","DOI":"10.18632\/oncotarget.7847","article-title":"DDA1 promotes stage IIB-IIC colon cancer progression by activating NF\u03baB\/CSN2\/GSK-3\u03b2 signaling","volume":"7","year":"2016","journal-title":"Oncotarget"},{"key":"2026041200364921000_2025.06.02.657296v2.114","doi-asserted-by":"crossref","first-page":"2183947","DOI":"10.1080\/13685538.2023.2183947","article-title":"Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer","volume":"26","year":"2023","journal-title":"Aging Male"},{"key":"2026041200364921000_2025.06.02.657296v2.115","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695081"},{"key":"2026041200364921000_2025.06.02.657296v2.116","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142158"},{"key":"2026041200364921000_2025.06.02.657296v2.117","doi-asserted-by":"crossref","first-page":"e65128","DOI":"10.1371\/journal.pone.0065128","article-title":"Transcriptome Analysis Reveals Novel Entry Mechanisms and a Central Role of SRC in Host Defense during High Multiplicity Mycobacterial Infection","volume":"8","year":"2013","journal-title":"PLoS ONE"},{"key":"2026041200364921000_2025.06.02.657296v2.118","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010770"},{"key":"2026041200364921000_2025.06.02.657296v2.119","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41590-024-02042-1","article-title":"A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells","volume":"26","year":"2025","journal-title":"Nat. Immunol"},{"key":"2026041200364921000_2025.06.02.657296v2.120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s13018-025-06037-y","article-title":"METTL14 mediates the m6A methylation of miR-29a-3p, thereby activating the MAP2K6 signaling pathway and exacerbating the inflammatory response associated with spinal tuberculosis. J","volume":"20","year":"2025","journal-title":"Orthop. Surg"},{"key":"2026041200364921000_2025.06.02.657296v2.121","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.3.374"},{"key":"2026041200364921000_2025.06.02.657296v2.122","doi-asserted-by":"publisher","DOI":"10.1016\/J.MIB.2024.102478"},{"key":"2026041200364921000_2025.06.02.657296v2.123","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/pharmaceutics18010106","article-title":"Targeting Bacterial Cell Wall Synthesis: Structural Insights and Emerging Therapeutic Strategies","volume":"18","year":"2026","journal-title":"Pharmaceutics"},{"key":"2026041200364921000_2025.06.02.657296v2.124","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.10.220"},{"key":"2026041200364921000_2025.06.02.657296v2.125","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1111\/bph.15838","article-title":"Host-directed anti-mycobacterial activity of colchicine, an anti-gout drug, via strengthened host innate resistance reinforced by the IL-1\u03b2\/PGE2 axis","volume":"179","year":"2022","journal-title":"Br. J. Pharmacol"},{"key":"2026041200364921000_2025.06.02.657296v2.126","first-page":"1300","article-title":"Bacterial fatty acid metabolism in modern antibiotic discovery","volume":"1862","year":"2017","journal-title":"Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids"},{"key":"2026041200364921000_2025.06.02.657296v2.127","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbrc.2007.11.002","article-title":"Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells","volume":"365","year":"2008","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"2026041200364921000_2025.06.02.657296v2.128","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15492-5"},{"key":"2026041200364921000_2025.06.02.657296v2.129","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2416"},{"key":"2026041200364921000_2025.06.02.657296v2.130","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22927-0"},{"key":"2026041200364921000_2025.06.02.657296v2.131","doi-asserted-by":"crossref","first-page":"797647","DOI":"10.3389\/fmed.2021.797647","article-title":"The Association of an Alpha-2 Adrenergic Receptor Agonist and Mortality in Patients With COVID-19","volume":"8","year":"2022","journal-title":"Front. Med"},{"key":"2026041200364921000_2025.06.02.657296v2.132","doi-asserted-by":"publisher","DOI":"10.1093\/ps\/85.3.452"},{"key":"2026041200364921000_2025.06.02.657296v2.133","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04895-5"},{"key":"2026041200364921000_2025.06.02.657296v2.134","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.364"},{"key":"2026041200364921000_2025.06.02.657296v2.135","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00686-15"},{"key":"2026041200364921000_2025.06.02.657296v2.136","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R600004200"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.06.02.657296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:37:06Z","timestamp":1775979426000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.06.02.657296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":136,"URL":"https:\/\/doi.org\/10.1101\/2025.06.02.657296","relation":{},"subject":[],"published":{"date-parts":[[2025,6,2]]},"subtype":"preprint"}}